This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppola, D
Right arrow Articles by Baserga, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coppola, D
Right arrow Articles by Baserga, R

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 July; 14(7): 4588-4595

A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.

D Coppola, A Ferber, M Miura, C Sell, C D'Ambrosio, R Rubin and R Baserga

Jefferson Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

ABSTRACT

When wild-type mouse embryo cells are stably transfected with a plasmid constitutively overexpressing the epidermal growth factor (EGF) receptor (EGFR), the resulting cells can grow in serum-free medium supplemented solely with EGF. Supplementation with EGF also induces in these cells the transformed phenotype (growth in soft agar). However, when the same EGFR expression plasmid is introduced and overexpressed in cells derived from littermate embryos in which the insulin-like growth factor I (IGF-I) receptor genes have been disrupted by homologous recombination, the resulting cells are unable to grow or to be transformed by the addition of EGF. Reintroduction into these cells (null for the IGF-I receptor) of a wild-type (but not of a mutant) IGF-I receptor restores EGF-mediated growth and transformation. Our results indicate that at least in mouse embryo fibroblasts, the EGFR requires the presence of a functional IGF-I receptor for its mitogenic and transforming activities.

Mol Cell Biol. 1994 July; 14(7): 4588-4595




This article has been cited by other articles:

  • Zha, J., O'Brien, C., Savage, H., Huw, L.-Y., Zhong, F., Berry, L., Lewis Phillips, G. D., Luis, E., Cavet, G., Hu, X., Amler, L. C., Lackner, M. R. (2009). Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer. Molecular Cancer Therapeutics 8: 2110-2121 [Abstract] [Full Text]  
  • Hu, Y. P., Patil, S. B., Panasiewicz, M., Li, W., Hauser, J., Humphrey, L. E., Brattain, M. G. (2008). Heterogeneity of Receptor Function in Colon Carcinoma Cells Determined by Cross-talk between Type I Insulin-like Growth Factor Receptor and Epidermal Growth Factor Receptor. Cancer Res. 68: 8004-8013 [Abstract] [Full Text]  
  • Chakraborty, A. K., Liang, K., DiGiovanna, M. P. (2008). Co-Targeting Insulin-Like Growth Factor I Receptor and HER2: Dramatic Effects of HER2 Inhibitors on Nonoverexpressing Breast Cancer. Cancer Res. 68: 1538-1545 [Abstract] [Full Text]  
  • Chi-Hang Li, J., Li, R. (2007). RAV12 Accelerates the Desensitization of Akt/PKB Pathway of Insulin-like Growth Factor I Receptor Signaling in COLO205. Cancer Res. 67: 8856-8864 [Abstract] [Full Text]  
  • Shekhar, M. P.V., Santner, S., Carolin, K. A., Tait, L. (2007). Direct Involvement of Breast Tumor Fibroblasts in the Modulation of Tamoxifen Sensitivity. Am. J. Pathol. 170: 1546-1560 [Abstract] [Full Text]  
  • Li, M., He, Z., Ermakova, S., Zheng, D., Tang, F., Cho, Y.-Y., Zhu, F., Ma, W.-Y., Sham, Y., Rogozin, E. A., Bode, A. M., Cao, Y., Dong, Z. (2007). Direct Inhibition of Insulin-Like Growth Factor-I Receptor Kinase Activity by (-)-Epigallocatechin-3-Gallate Regulates Cell Transformation. Cancer Epidemiol. Biomarkers Prev. 16: 598-605 [Abstract] [Full Text]  
  • Jones, H. E, Gee, J. M W, Hutcheson, I. R, Knowlden, J. M, Barrow, D., Nicholson, R. I (2006). Growth factor receptor interplay and resistance in cancer. Endocr Relat Cancer 13: S45-S51 [Abstract] [Full Text]  
  • Spence, S. L., Shaffer, A. L., Staudt, L. M., Amde, S., Manney, S., Terry, C., Weisz, K., Nissley, P. (2006). Transformation of Late Passage Insulin-Like Growth Factor-I Receptor Null Mouse Embryo Fibroblasts by SV40 T Antigen.. Cancer Res. 66: 4233-4239 [Abstract] [Full Text]  
  • Takaoka, M., Smith, C. E., Mashiba, M. K., Okawa, T., Andl, C. D., El-Deiry, W. S., Nakagawa, H. (2006). EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G404-G416 [Abstract] [Full Text]  
  • Matthews, L. C., Taggart, M. J., Westwood, M. (2005). Effect of Cholesterol Depletion on Mitogenesis and Survival: The Role of Caveolar and Noncaveolar Domains in Insulin-Like Growth Factor-Mediated Cellular Function. Endocrinology 146: 5463-5473 [Abstract] [Full Text]  
  • Knowlden, J. M., Hutcheson, I. R., Barrow, D., Gee, J. M. W., Nicholson, R. I. (2005). Insulin-Like Growth Factor-I Receptor Signaling in Tamoxifen-Resistant Breast Cancer: A Supporting Role to the Epidermal Growth Factor Receptor. Endocrinology 146: 4609-4618 [Abstract] [Full Text]  
  • Furukawa, M., Raffeld, M., Mateo, C., Sakamoto, A., Moody, T. W., Ito, T., Venzon, D. J., Serrano, J., Jensen, R. T. (2005). Increased Expression of Insulin-Like Growth Factor I and/or Its Receptor in Gastrinomas Is Associated with Low Curability, Increased Growth, and Development of Metastases. Clin. Cancer Res. 11: 3233-3242 [Abstract] [Full Text]  
  • Ibrahim, Y. H., Yee, D. (2005). Insulin-Like Growth Factor-I and Breast Cancer Therapy. Clin. Cancer Res. 11: 944s-950s [Abstract] [Full Text]  
  • Ahmad, T., Farnie, G., Bundred, N. J., Anderson, N. G. (2004). The Mitogenic Action of Insulin-like Growth Factor I in Normal Human Mammary Epithelial Cells Requires the Epidermal Growth Factor Receptor Tyrosine Kinase. J. Biol. Chem. 279: 1713-1719 [Abstract] [Full Text]  
  • Sekharam, M., Zhao, H., Sun, M., Fang, Q., Zhang, Q., Yuan, Z., Dan, H. C., Boulware, D., Cheng, J. Q., Coppola, D. (2003). Insulin-like Growth Factor 1 Receptor Enhances Invasion and Induces Resistance to Apoptosis of Colon Cancer Cells through the Akt/Bcl-xL Pathway. Cancer Res. 63: 7708-7716 [Abstract] [Full Text]  
  • Yasumaru, M., Tsuji, S., Tsujii, M., Irie, T., Komori, M., Kimura, A., Nishida, T., Kakiuchi, Y., Kawai, N., Murata, H., Horimoto, M., Sasaki, Y., Hayashi, N., Kawano, S., Hori, M. (2003). Inhibition of Angiotensin II Activity Enhanced the Antitumor Effect of Cyclooxygenase-2 Inhibitors via Insulin-Like Growth Factor I Receptor Pathway. Cancer Res. 63: 6726-6734 [Abstract] [Full Text]  
  • Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parikh, A. A., Bucana, C. D., Evans, D. B., Semenza, G. L., Ellis, L. M. (2003). Regulation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer. Am. J. Pathol. 163: 1001-1011 [Abstract] [Full Text]  
  • Lee, A. V., Schiff, R., Cui, X., Sachdev, D., Yee, D., Gilmore, A. P., Streuli, C. H., Oesterreich, S., Hadsell, D. L. (2003). New Mechanisms of Signal Transduction Inhibitor Action: Receptor Tyrosine Kinase Down-Regulation and Blockade of Signal Transactivation. Clin. Cancer Res. 9: 516s-523s [Abstract] [Full Text]  
  • Kobayashi, T., Kamata, K. (2002). Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 283: H1761-H1768 [Abstract] [Full Text]  
  • Valentinis, B, Baserga, R (2001). IGF-I receptor signalling in transformation and differentiation. Mol. Pathol. 54: 133-137 [Abstract] [Full Text]  
  • Gatzka, M., Prisco, M., Baserga, R. (2000). Stabilization of the Ras Oncoprotein by the Insulin-like Growth Factor 1 Receptor during Anchorage-independent Growth. Cancer Res. 60: 4222-4230 [Abstract] [Full Text]  
  • Daniel, R., He, Z., Carmichael, K. P., Halper, J., Bateman, A. (2000). Cellular Localization of Gene Expression for Progranulin. J. Histochem. Cytochem. 48: 999-1010 [Abstract] [Full Text]  
  • Dews, M., Prisco, M., Peruzzi, F., Romano, G., Morrione, A., Baserga, R. (2000). Domains of the Insulin-Like Growth Factor I Receptor Required for the Activation of Extracellular Signal-Regulated Kinases. Endocrinology 141: 1289-1300 [Abstract] [Full Text]  
  • Nakamura, K., Hongo, A., Kodama, J., Miyagi, Y., Yoshinouchi, M., Kudo, T. (2000). Down-Regulation of the Insulin-like Growth Factor I Receptor by Antisense RNA Can Reverse the Transformed Phenotype of Human Cervical Cancer Cell Lines. Cancer Res. 60: 760-765 [Abstract] [Full Text]  
  • Lu, Z., Hornia, A., Joseph, T., Sukezane, T., Frankel, P., Zhong, M., Bychenok, S., Xu, L., Feig, L. A., Foster, D. A. (2000). Phospholipase D and RalA Cooperate with the Epidermal Growth Factor Receptor To Transform 3Y1 Rat Fibroblasts. Mol. Cell. Biol. 20: 462-467 [Abstract] [Full Text]  
  • Molnick, M., Jaskoll, T. (2000). Mouse Submandibular Gland Morphogenesis: a Paradigm for Embryonic Signal Processing. CROBM 11: 199-215 [Abstract] [Full Text]  
  • Hornia, A., Lu, Z., Sukezane, T., Zhong, M., Joseph, T., Frankel, P., Foster, D. A. (1999). Antagonistic Effects of Protein Kinase C alpha and delta on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor. Mol. Cell. Biol. 19: 7672-7680 [Abstract] [Full Text]  
  • Zanocco-Marani, T., Bateman, A., Romano, G., Valentinis, B., He, Z.-H., Baserga, R. (1999). Biological Activities and Signaling Pathways of the Granulin/Epithelin Precursor. Cancer Res. 59: 5331-5340 [Abstract] [Full Text]  
  • Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., Arnold, A. (1999). The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation. Endocr. Rev. 20: 501-534 [Abstract] [Full Text]  
  • He, Z., Bateman, A. (1999). Progranulin Gene Expression Regulates Epithelial Cell Growth and Promotes Tumor Growth in Vivo. Cancer Res. 59: 3222-3229 [Abstract] [Full Text]  
  • Coppola, D., Saunders, B., Fu, L., Mao, W., Nicosia, S. V. (1999). The Insulin-like Growth Factor 1 Receptor Induces Transformation and Tumorigenicity of Ovarian Mesothelial Cells and Down-Regulates Their Fas-Receptor Expression. Cancer Res. 59: 3264-3270 [Abstract] [Full Text]  
  • Hirano, H., Lopes, M. B. S., Laws, E. R. Jr., Asakura, T., Goto, M., Carpenter, J. E., Karns, L. R., VandenBerg, S. R. (1999). Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neuro Oncol Duke 1: 109-119 [Abstract]  
  • Scheidegger, K. J., Du, J., Delafontaine, P. (1999). Distinct and Common Pathways in the Regulation of Insulin-like Growth Factor-1 Receptor Gene Expression by Angiotensin II and Basic Fibroblast Growth Factor. J. Biol. Chem. 274: 3522-3530 [Abstract] [Full Text]  
  • Li, W., Jiang, Y.-X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., Pierce, J. H., Wang, L.-H. (1998). Protein Kinase C-delta Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation. Mol. Cell. Biol. 18: 5888-5898 [Abstract] [Full Text]  
  • Xu, S.-Q., Tang, D., Chamberlain, S., Pronk, G., Masiarz, F. R., Kaur, S., Prisco, M., Zanocco-Marani, T., Baserga, R. (1998). The Granulin/Epithelin Precursor Abrogates the Requirement for the Insulin-like Growth Factor 1 Receptor for Growth in Vitro. J. Biol. Chem. 273: 20078-20083 [Abstract] [Full Text]  
  • Lipson, K. E., Pang, L., Huber, L. J., Chen, H., Tsai, J.-M., Hirth, P., Gazit, A., Levitzki, A., Mcmahon, G. (1998). Inhibition of Platelet-Derived Growth Factor and Epidermal Growth Factor Receptor Signaling Events after Treatment of Cells with Specific Synthetic Inhibitors of Tyrosine Kinase Phosphorylation. J. Pharmacol. Exp. Ther. 285: 844-852 [Abstract] [Full Text]  
  • Liu, J.-L., Blakesley, V. A., Gutkind, J. S., LeRoith, D. (1997). The Constitutively Active Mutant Galpha 13 Transforms Mouse Fibroblast Cells Deficient in Insulin-like Growth Factor-I Receptor. J. Biol. Chem. 272: 29438-29441 [Abstract] [Full Text]  
  • Burke, J. J. II, Talavera, F., Menon, K. M. J. (1997). Regulation of PTP1D mRNA by Peptide Growth Factors in the Human Endometrial Cell Line HEC-1-A. Reproductive Sciences 4: 310-315 [Abstract]  
  • Morrione, A., Valentinis, B., Xu, S.-q., Yumet, G., Louvi, A., Efstratiadis, A., Baserga, R. (1997). Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. USA 94: 3777-3782 [Abstract] [Full Text]  
  • Huang, C., Schmid, P. C., Ma, W.-Y., Schmid, H. H.O., Dong, Z. (1997). Phosphatidylinositol-3 Kinase Is Necessary for 12-O-Tetradecanoylphorbol-13-acetate-induced Cell Transformation and Activated Protein 1Activation. J. Biol. Chem. 272: 4187-4194 [Abstract] [Full Text]  
  • Peterson, J. E., Kulik, G., Jelinek, T., Reuter, C. W.M., Shannon, J. A., Weber, M. J. (1996). Src Phosphorylates the Insulin-like Growth Factor Type I Receptor on the Autophosphorylation Sites. REQUIREMENT FOR TRANSFORMATION BY src. J. Biol. Chem. 271: 31562-31571 [Abstract] [Full Text]  
  • Karnieli, E., Werner, H., Rauscher, F. J. III, Benjamin, L. E., LeRoith, D. (1996). The IGF-I Receptor Gene Promoter Is a Molecular Target for the Ewing's Sarcoma-Wilms' Tumor 1Fusion Protein. J. Biol. Chem. 271: 19304-19309 [Abstract] [Full Text]  
  • Li, S., Resnicoff, M., Baserga, R. (1996). Effect of Mutations at Serines 1280-1283 on the Mitogenic and Transforming Activities of the Insulin-like Growth Factor I Receptor. J. Biol. Chem. 271: 12254-12260 [Abstract] [Full Text]  
  • Jiang, Y., Chan, J. L.-K., Zong, C. S., Wang, L.-H. (1996). Effect of Tyrosine Mutations on the Kinase Activity and Transforming Potential of an Oncogenic Human Insulin-like Growth Factor I Receptor. J. Biol. Chem. 271: 160-167 [Abstract] [Full Text]  
  • Miura, M., Surmacz, E., Burgaud, J.-L., Baserga, R. (1995). Different Effects on Mitogenesis and Transformation of a Mutation at Tyrosine 1251 of the Insulin-like Growth Factor I Receptor. J. Biol. Chem. 270: 22639-22644 [Abstract] [Full Text]  
  • Takahashi, K., Yonezawa, K., Nishimoto, I. (1995). Insulin-like Growth Factor I Receptor Activated by a Transmembrane Mutation. J. Biol. Chem. 270: 19041-19045 [Abstract] [Full Text]  
  • Scheidegger, K. J., Cenni, B., Picard, D., Delafontaine, P. (2000). Estradiol Decreases IGF-1 and IGF-1 Receptor Expression in Rat Aortic Smooth Muscle Cells. MECHANISMS FOR ITS ATHEROPROTECTIVE EFFECTS. J. Biol. Chem. 275: 38921-38928 [Abstract] [Full Text]  
  • Giraud, S., Greco, A., Brink, M., Diaz, J.-J., Delafontaine, P. (2001). Translation Initiation of the Insulin-like Growth Factor I Receptor mRNA Is Mediated by an Internal Ribosome Entry Site. J. Biol. Chem. 276: 5668-5675 [Abstract] [Full Text]  
  • Sachdev, P., Jiang, Y.-X., Li, W., Miki, T., Maruta, H., Nur-e-Kamal, M. S. A., Wang, L.-H. (2001). Differential Requirement for Rho Family GTPases in an Oncogenic Insulin-like Growth Factor-I Receptor-induced Cell Transformation. J. Biol. Chem. 276: 26461-26471 [Abstract] [Full Text]  
  • Dupont, J., Fernandez, A. M., Glackin, C. A., Helman, L., LeRoith, D. (2001). Insulin-like Growth Factor 1 (IGF-1)-induced Twist Expression Is Involved in the Anti-apoptotic Effects of the IGF-1 Receptor. J. Biol. Chem. 276: 26699-26707 [Abstract] [Full Text]  
  • Du, J., Brink, M., Peng, T., Mottironi, B., Delafontaine, P. (2001). Thrombin Regulates Insulin-Like Growth Factor-1 Receptor Transcription in Vascular Smooth Muscle : Characterization of the Signaling Pathway. Circ. Res. 88: 1044-1052 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»